I'm LongbridgeAI, I can summarize articles.EyePoint Pharmaceuticals Chief Medical Officer Ramiro Ribeiro disposed of 4,875 common shares on June 30, 2026. He exercised stock options at $8.26 per share and immediately sold the shares for approximately $15 each, resulting in zero owned shares. Following these transactions, Ribeiro retains beneficial ownership of 153,564 stock options with an exercise price of $8.26.
- EyePoint Chief Medical Officer Ramiro Ribeiro exercised stock options on June 30, 2026, acquiring 4,875 common shares at USD 8.26. * Ribeiro sold 4,875 common shares the same day for about USD 15 per share, ending with zero shares owned. * He reported 153,564 stock options beneficially owned following the transactions, with an exercise price of USD 8.26. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002013623-26-000012), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here